{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T14:47:30Z","timestamp":1776350850322,"version":"3.51.2"},"reference-count":28,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Urology"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1016\/j.eururo.2012.01.044","type":"journal-article","created":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T19:34:42Z","timestamp":1328124882000},"page":"704-712","source":"Crossref","is-referenced-by-count":29,"title":["Glycine Transporter Type 2 (GlyT2) Inhibitor Ameliorates Bladder Overactivity and Nociceptive Behavior in Rats"],"prefix":"10.1016","volume":"62","author":[{"given":"Satoru","family":"Yoshikawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiko","family":"Oguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhito","family":"Funahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William C.","family":"de Groat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Yoshimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.eururo.2012.01.044_bib0005","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1016\/S0022-5347(05)64261-9","article-title":"Current and future pharmacological treatment for overactive bladder","volume":"168","author":"Yoshimura","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2012.01.044_bib0010","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/nau.20837","article-title":"Neural control of the lower urinary tract: peripheral and spinal mechanisms","volume":"29","author":"Birder","year":"2010","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.eururo.2012.01.044_bib0015","series-title":"Chronic abdominal and visceral pain: theory and practice.","first-page":"495","article-title":"Interstitial cystitis and related painful bladder syndromes: pathophysiology","author":"Yoshimura","year":"2007"},{"key":"10.1016\/j.eururo.2012.01.044_bib0020","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1007\/s00018-005-5107-2","article-title":"The glycinergic control of spinal pain processing","volume":"62","author":"Zeilhofer","year":"2005","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.eururo.2012.01.044_bib0025","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1097\/01.ju.0000180415.69705.7a","article-title":"Intrathecal or dietary glycine inhibits bladder and urethral activity in rats with spinal cord injury","volume":"174","author":"Miyazato","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2012.01.044_bib0030","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1111\/j.1442-2042.2008.02079.x","article-title":"Changes of bladder activity and glycine levels in the lumbosacral cord after partial bladder outlet obstruction in rats","volume":"15","author":"Miyazato","year":"2008","journal-title":"Int J Urol"},{"key":"10.1016\/j.eururo.2012.01.044_bib0035","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1111\/j.1442-2042.2006.01653.x","article-title":"Serum amino acids as indicators of cerebrospinal neuronal activity in patients with micturition disorders","volume":"13","author":"Nishijima","year":"2006","journal-title":"Int J Urol"},{"key":"10.1016\/j.eururo.2012.01.044_bib0040","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.tibs.2005.04.004","article-title":"Glycine transporters: essential regulators of neurotransmission","volume":"30","author":"Eulenburg","year":"2005","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.eururo.2012.01.044_bib0045","doi-asserted-by":"crossref","first-page":"3952","DOI":"10.1523\/JNEUROSCI.15-05-03952.1995","article-title":"Glycine transporters are differentially expressed among CNS cells","volume":"15","author":"Zafra","year":"1995","journal-title":"J Neurosci"},{"key":"10.1016\/j.eururo.2012.01.044_bib0050","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1111\/j.1460-9568.1995.tb01125.x","article-title":"Regional distribution and developmental variation of the glycine transporters GLYT1 and GLYT2 in the rat CNS","volume":"7","author":"Zafra","year":"1995","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.eururo.2012.01.044_bib0055","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.bcp.2011.02.003","article-title":"Glycine transporter 1 as a potential therapeutic target for schizophrenia-related symptoms: evidence from genetically modified mouse models and pharmacological inhibition","volume":"81","author":"Mohler","year":"2011","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.eururo.2012.01.044_bib0060","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.pbb.2008.06.009","article-title":"Characterization of SSR 103800, a selective inhibitor of the glycine transporter-1 in models predictive of therapeutic activity in schizophrenia","volume":"91","author":"Boulay","year":"2008","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.eururo.2012.01.044_bib0065","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1111\/j.1460-9568.2008.06433.x","article-title":"Rescue of hippocampal LTP and learning deficits in a rat model of psychosis by inhibition of glycine transporter-1 (GlyT1)","volume":"28","author":"Manahan-Vaughan","year":"2008","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.eururo.2012.01.044_bib0070","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.pharmthera.2009.03.018","article-title":"Glycine transporter inhibitors as a novel drug discovery strategy for neuropathic pain","volume":"123","author":"Dohi","year":"2009","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.eururo.2012.01.044_bib0075","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1213\/ANE.0b013e3181c7ebbb","article-title":"The antinociceptive effect of intrathecal administration of glycine transporter-2 inhibitor ALX1393 in a rat acute pain model","volume":"110","author":"Haranishi","year":"2010","journal-title":"Anesth Analg"},{"key":"10.1016\/j.eururo.2012.01.044_bib0080","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.juro.2007.08.090","article-title":"Effects of intravesical instillation of resiniferatoxin on bladder function and nociceptive behavior in freely moving, conscious rats","volume":"179","author":"Saitoh","year":"2008","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2012.01.044_bib0085","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.pain.2009.06.014","article-title":"Prefrontal cortex and spinal cord mediated anti-neuropathy and analgesia induced by sarcosine, a glycine-T1 transporter inhibitor","volume":"145","author":"Centeno","year":"2009","journal-title":"Pain"},{"key":"10.1016\/j.eururo.2012.01.044_bib0090","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S0014-4886(03)00175-4","article-title":"Inhibitory effect of intrathecal glycine on the micturition reflex in normal and spinal cord injury rats","volume":"183","author":"Miyazato","year":"2003","journal-title":"Exp Neurol"},{"key":"10.1016\/j.eururo.2012.01.044_bib0095","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.neuroscience.2004.04.006","article-title":"Positive N-methyl-D-aspartate receptor modulation by selective glycine transporter-1 inhibition in the rat dorsal spinal cord in vivo","volume":"126","author":"Whitehead","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.eururo.2012.01.044_bib0100","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/325529a0","article-title":"Glycine potentiates the NMDA response in cultured mouse brain neurons","volume":"325","author":"Johnson","year":"1987","journal-title":"Nature"},{"key":"10.1016\/j.eururo.2012.01.044_bib0105","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/nature01497","article-title":"Glycine binding primes NMDA receptor internalization","volume":"422","author":"Nong","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.eururo.2012.01.044_bib0110","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S0896-6273(03)00725-6","article-title":"Glycine transporters not only take out the garbage, they recycle","volume":"40","author":"Brasnjo","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.eururo.2012.01.044_bib0115","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1046\/j.1471-4159.1995.64031026.x","article-title":"Localization of glycine neurotransmitter transporter (GLYT2) reveals correlation with the distribution of glycine receptor","volume":"64","author":"Jursky","year":"1995","journal-title":"J Neurochem"},{"key":"10.1016\/j.eururo.2012.01.044_bib0120","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.neuron.2005.01.028","article-title":"The beta subunit determines the ligand binding properties of synaptic glycine receptors","volume":"45","author":"Grudzinska","year":"2005","journal-title":"Neuron"},{"key":"10.1016\/j.eururo.2012.01.044_bib0125","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/978-1-4684-5907-4_37","article-title":"Structure and expression of inhibitory glycine receptors","volume":"287","author":"Betz","year":"1991","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.eururo.2012.01.044_bib0130","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.neulet.2008.09.012","article-title":"Differential effects of spinally applied glycine transporter inhibitors on nociception in a rat model of neuropathic pain","volume":"445","author":"Hermanns","year":"2008","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.eururo.2012.01.044_bib0135","doi-asserted-by":"crossref","first-page":"522","DOI":"10.2174\/138161210790361452","article-title":"Strategies to enhance N-methyl-D-aspartate receptor-mediated neurotransmission in schizophrenia, a critical review and meta-analysis","volume":"16","author":"Tsai","year":"2010","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.eururo.2012.01.044_bib0140","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1017\/S1461145709990939","article-title":"A randomized, double-blind, placebo-controlled comparison study of sarcosine (N-methylglycine) and D-serine add-on treatment for schizophrenia","volume":"13","author":"Lane","year":"2010","journal-title":"Int J Neuropsychopharmacol"}],"container-title":["European Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283812001200?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283812001200?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,23]],"date-time":"2019-06-23T00:36:58Z","timestamp":1561250218000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0302283812001200"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["S0302283812001200"],"URL":"https:\/\/doi.org\/10.1016\/j.eururo.2012.01.044","relation":{},"ISSN":["0302-2838"],"issn-type":[{"value":"0302-2838","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]}}}